-
Recurrent miscarriage and low-titer antiphospholipid antibodies Clin. Rheumatol. (IF 3.4) Pub Date : 2024-04-01
Abstract Objective To evaluate the clinical features and pregnancy outcomes in patients experiencing recurrent miscarriage (RM) with either low-titer or medium-high titer positivity of antiphospholipid antibodies (aPL). Methods A retrospective review of medical records was conducted for patients with aPL positivity and recurrent miscarriage between 2018 and 2022. The clinical features, treatment strategies
-
Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity Clin. Rheumatol. (IF 3.4) Pub Date : 2024-04-01
Abstract Background Type 2 systemic lupus erythematosus (SLE) symptoms, including fatigue, fibromyalgia, and brain fog, contribute to poor health-related quality of life (HRQoL) in patients with lupus. To test the hypothesis that Type 1 (classical inflammatory lupus) activity is associated with Type 2 SLE activity, we characterized the features of Type 2 SLE in patients with a range of lupus nephritis
-
Comparison of the efficacy and safety of benzbromarone and febuxostat in gout and hyperuricemia: a systematic review and meta-analysis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-16 Fan Wu, Lvyi Chen, Yimei Du
-
Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-16 Fangyi Lu, Qilin Chen, Xin Qi, Menglin Cong, Xinyue Dai, Huaxiang Liu, Yunfeng Li
-
Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-15 Yaqi Zhao, Wei Xu, Wenfeng Gao, Xinya Li, Baocheng Liu, Suyan Yan, Zhenzhen Ma, Qingrui Yang
-
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-12
Abstract Objectives To evaluate the association between enthesitis resolution (ER) and dactylitis resolution (DR) and meaningful improvements in patient-reported outcomes (PROs) among biologic-naïve patients with PsA receiving guselkumab in the DISCOVER-2 study. Methods Enthesitis and dactylitis, characteristic lesions of PsA, were evaluated by independent assessors using the Leeds Enthesitis Index
-
Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-12 Panagiotis Athanassiou, Pelagia Katsimbri, Andreas Bounas, Sοusana Gazi, Theodosios Sarikoudis, Victoria Syrigou, Dimitrios Boumpas
-
Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-11 Nuran Öz, Halise Hande Gezer, Selin Cilli Hayıroğlu, Mehmet Tuncay Duruöz
-
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-09 Geoffrey Littlejohn, Joanna Leadbetter, Belinda E. Butcher, Marie Feletar, Catherine O’Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
-
Clinical characteristics of patients with connective tissue disease–related interstitial lung disease: a retrospective analysis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-09 Seda Colak, Emre Tekgoz, Ezgi Cimen Gunes, Nesrin Ocal, Deniz Dogan, Canturk Tasci, Muhammet Cinar, Sedat Yilmaz
-
A statistical symptomatic evaluation on SAPHO syndrome from 56 cases of confirmed diagnosis and 352 cases of non-SAPHO involvement Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-06 Cheng Qiu, Manyu Li, Qingrong Wu, Jian Zhou, Tianyi Liu, Jinghang Li, Jingwei Liu, Lin Cheng, Yu Hong, Dan Luo, Jun Yan, Wenping Pan, Zhankui Wang, Qing Wang, Xinyu Liu, Lianlei Wang
-
Coffee intake reduced gout risk by decreasing urate and urea while increasing SHBG levels in plasma: a mediation Mendelian randomization study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-06 Tingting Qin, Yuxin Chu, Yi Yao, Cai Zhang, Bin Xu, Qibin Song
-
Increased carotid intima-media thickness in patients with radiographic axial spondyloarthritis compared to controls and associations with markers of inflammation Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-06
Abstract Objective There is an increased risk for cardiovascular disease (CVD) in patients with radiographic axial spondyloarthritis (r-axSpA). In this cross-sectional study, we aimed to, overall and stratified by sex, (i) compare ultrasound derived carotid intima media thickness (cIMT), between patients and controls, and (ii) investigate associations between cIMT, clinical disease activity and inflammation-related
-
Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA): does duration matter? Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-05
Abstract Background To compare outcomes of a short and long weaning strategy of anti-tumor necrosis factor (aTNF) in our prospective juvenile idiopathic arthritis (JIA) cohort. Research design and methods JIA patients on subcutaneous adalimumab with at least 6 months of follow-up were recruited (May 2010–Jan 2022). Once clinical remission on medication (CRM) was achieved, adalimumab was weaned according
-
Mendelian randomization study on causal association of FAM210B with drug-induced lupus Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-04 Yaqi Xu, Ran Gao, Min Zhang, Qi Zeng, Shan Zhou, Gaizhi Zhu, Wenting Su, Renxi Wang
-
Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-04
Abstract Objectives (I) To identify and measure the clinical consequences of a delayed diagnosis in patients with primary obstetric antiphospholipid syndrome (POAPS), in terms of time and events associated to antiphospholipid syndrome (APS), and (II) to evaluate the impact of their treatment status on perinatal outcomes, before and after diagnosis. Methods This retrospective multicentre study included
-
Geriatric nutrition risk index: a more powerful index identifying muscle mass loss in patients with rheumatoid arthritis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-04 Jie Pan, Tao Wu, Jian-Da Ma, Pei-Wen Jia, Yao-Wei Zou, Zhi-Ming Ouyang, Hu-Wei Zheng, Jian-Zi Lin, Qian Zhang, Ye Lu, Le-Feng Chen, Ze-Hong Yang, Ying-Ying Zhu, Qing-Yang Song, Yun Su, Lin-Wang Su, Wei Dai, Jun Dai, Lie Dai
-
Immune profiling analysis of double-negative T cells in patients with systemic sclerosis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-03-04 Dongdong Zhang, Mihribangvl Alip, Hongzhen Chen, Dan Wu, Huimin Zhu, Yichen Han, Xinran Yuan, Xuebing Feng, Lingyun Sun, Dandan Wang
-
ANCA-associated vasculitis presenting with isolated neurological manifestations in a patient with cocaine abuse: a case report and literature review Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-28 Fazila Aseem, Victor Lin, Abigail L. Gilbert, Alfredo C. Rivadeneira, J. Charles Jennette, Thomas W. Bouldin, Freshta Khoshbakht, Yueh. Z. Lee, Kelly Chamberlin, Aaron Gelinne, Anahit C. Mehrabyan, Bushra Javed, Irena Dujmovic Basuroski, Monica M. Diaz
-
Asymmetric darkened knuckles with subclinical myopathy revealed anti-Mi2b positive dermatomyositis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-26 Ritasman Baisya
-
Increased inferior vena cava wall thickness as a sign of extensive venous inflammation in Behçet’s Disease Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-22 Seda Kutluğ Ağaçkıran, Murat Sünbül, Zekeriya Doğan, Haner Direskeneli, Fatma Alibaz-Oner
-
Identification and verification of inflammatory biomarkers for primary Sjögren’s syndrome Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-20 Xiaodan Liu, Haojie Wang, Xiao Wang, Xiaodan Jiang, Yinji Jin, Ying Han, Zhihui Zhang
-
Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-20 Bo Wang, Jinmin Liu, Lianggong Zhao
-
Modifying loading during gait leads to biochemical changes in serum cartilage oligomeric matrix protein concentrations in a subgroup of individuals with anterior cruciate ligament reconstruction Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-15 Cortney Armitano-Lago, Alyssa Evans-Pickett, Hope Davis-Wilson, Amanda Munsch, Lara Longobardi, Helen Willcockson, Todd A. Schwartz, Jason R. Franz, Brian Pietrosimone
-
Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-14 Daniel G. Fernández-Ávila, Daniela Patiño-Hernández, Socorro Moreno-Luna, Lorena Brance, Álvaro Arbeláez, Antonio Cachafeiro Vilar, Carlos Lozada, Carlos Ríos, Carlos Toro, Claudia Ramírez, Guillermo Pons-Estel, Manuel Ugarte-Gil, María Narváez, Miguel Albanese, Orlando Roa, Oscar Ruiz, Paula Burgos, Ricardo Xavier, Yurilis Fuentes, Enrique Soriano
-
A rare twist: COVID-19 infection masquerading as IgA vasculitis in a hemophilia a patient Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-14 Khalid A. Alnaqbi, Nasser Abunamous, Tausif Saleem
-
Systemic lupus erythematosus and Atopic dermatitis: A two sample Mendelian randomization study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-13
Abstract Background Systemic lupus erythematosus (SLE) and atopic dermatitis (AD) are common diseases in human populations. Previous studies have suggested a potential association between SLE and AD. However, the causal relationship and direction between the two conditions remain unclear. Objective The aim of this study is to evaluate the causal relationship between SLE and AD. Methods In this study
-
Comparison of bone mineral density of osteoporotic and osteopenia menopausal women treated with oral bisphosphonates before stopping the treatment and 1 year after drug holiday period Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-13
Abstract Background Osteoporosis is a skeletal and bone disorder characterized by bone fractures and decreased bone mineral density (BMD). Bisphosphonates have a great tendency to bind to minerals, and their long-term use can increase the risk of bone fragility in patients. Stopping bisphosphonates after a period of time is called a drug holiday (DH). Recent evidence has shown that patients’ BMD may
-
Classifying systemic lupus erythematosus using laboratory items alone: a preliminary study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-12
Abstract Objectives To explore the performance of laboratory items alone in systemic lupus erythematosus (SLE) classification. Methods Our cohort consisted of 352 and 385 (control) patients with and without SLE. This study evaluated the performance of the American College of Rheumatology (ACR)-1997, Systemic Lupus International Collaborating Clinics (SLICC)-2012, European League Against Rheumatism
-
Optimal time of starting tocilizumab in acute phase of adult-onset Still’s disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-12 Satoshi Suzuki, Yuko Kataoka, Tomoya Otani, Yukino Taniguchi, Keigo Ikeda, Naoto Tamura, Shinji Morimoto
-
Prognostic factors of fungal infection in anti-melanoma differentiation-associated gene 5 antibody-positive associated interstitial lung disease Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-12
Abstract Objective To investigate the potential risk factors for mortality in fungal infection in anti-melanoma differentiation-associated gene 5 antibody-positive associated interstitial lung disease (MDA5-ILD). Methods Patients diagnosed with MDA5-ILD from April 2017 to November 2022 were included. The demographic data, laboratory examinations, therapeutic and follow-up information were recorded
-
Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-10 Anna Lichtiger, Golfam Fadaei, Clement E. Tagoe
Autoimmune thyroid disease (AITD) is the most prevalent autoimmune disease. It shares multiple genetic, clinical, and serologic characteristics with rheumatoid arthritis (RA). Although frequently described as a classic form of single-organ autoimmunity, the AITD disease burden in a subset of patients extends well beyond the thyroid gland. This review explores the complex interaction between the two
-
Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-09 Maya Yamato, Tsuyoshi Shirai, Yusho Ishii, Hiroko Sato, Tomonori Ishii, Hiroshi Fujii
-
Diagnostic value of contrast-enhanced ultrasound in the activity of idiopathic retroperitoneal fibrosis: a retrospective study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-08 Ling Ren, Xiang Fei, Yurong Zhao, Fang Xie, Shaowei Xue, Nan Li, Fang Nie, Yukun Luo
-
Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-07 Xiaoyan Xing, Yuzhou Gan, Wanxing Mo, Jian Zhang, Naidi Wang, Kai Zhang, Ke Ma, Lihua Zhang, Lin Ma, Dan Lu, Yuhui Li, Jing He
-
Sjögren’s disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-07 Bradley R. Bohman, Hunter S. Dowds, Temisan E. Blagogee, Robert W. Ike, Karen E. Hansen, Sara S. McCoy
-
Association between anthropometric indices and hyperuricemia: a nationwide study in China Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-05 Deshi Chen, Cihang Lu, Kang Chen, Tingting Liu, Yongze Li, Zhongyan Shan, Weiping Teng
-
The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-05 Azhar M. Nomair, Abeer Abdelati, Fatma I. Dwedar, Rehab Elnemr, Yasmine N. Kamel, Hanan M. Nomeir
-
Myofibroblast and pro-fibrotic cytokines in fibrosis of IgG4-related disease (IgG4-RD) patients from South Asia: preliminary data Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-03
Abstract Introduction Fibrosis is a typical pathological characteristic in IgG4-RD patients and often irreversible. There exists a lack of suitable markers for detection of earlier onset of fibrosis in various organs in IgG4-RD patients. Hence, this study aims at analysing ambispectively the myofibroblasts and the pro-fibrotic cytokines, IFN gamma and IL-33 involved in IgG4-RD associated fibrosis in
-
Digital gangrene in systemic sclerosis patients: not only due to the microvascular disease Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-02 Min Hui, Jiaxin Zhou, Mengtao Li, Qian Wang, Jiuliang Zhao, Yong Hou, Dong Xu, Xiaofeng Zeng
-
Risk of gout flare after medication: prescription symmetry sequence analysis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-02
Abstract Objectives The research aimed to study the following questions: (1) five well-known gout-related medications were selected to test the validity of the prescription symmetry sequence analysis in Taiwan; (2) four exploratory medications were selected to test their relation to gout flares. Methods We utilized the 2003–2017 dataset of the Taiwan National Health Insurance Program containing all
-
Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-02-02 Li Zhang, Min Tan, Jing Mao, Juan Zhang, Xiao-Yuan Wang, Yan Zhang, Rui-Xue Duo, Jia-Yao Hao, Hai-Li Shen
-
Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-31 Arwa S. Amer, Samia M. Abdel moneam, Nashwa I. Hashaad, Eman M. Yousef, Dalia M. Abd El-Hassib
-
Effect of high-dose intravenous methylprednisolone pulse (IVMP) therapy in the survival of patients with anti-melanoma differentiation-associated gene 5-related rapidly progressive interstitial lung disease: a retrospective analysis Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-30 Li Fan, Yan Li, Wenting Lyu, Qingqing Xu, Yujuan Gao, Xiaohua Qiu, Hourong Cai, Jinghong Dai
-
Burden of osteoarthritis in China, 1990–2019: findings from the Global Burden of Disease Study 2019 Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-30
Abstract This study aimed to report the most current data on the incidence and disability-adjusted life years (DALY) associated with osteoarthritis in China from 1990 to 2019. Publicly available modelled data from Global Burden of Disease Study (GBD) 2019 were used. The incidence and DALY, due to osteoarthritis in China, stratified by sex, trends of associated risk factors, assess the age, period,
-
Fatty infiltration in the posterior muscles of the lower extremities as an MRI feature in antimitochondrial antibody–associated myopathy Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-29 Yuli Wang, Zhenguo Huang, Jieping Lei, Xin Lu, Sizhao Li, Guochun Wang, Sheng Xie, Lu Zhang
-
Validation of new immune and inflammation-related diagnostic biomarkers for RA Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-29 Xijie Bao
-
The effect of COVID-19 infection on patients with rheumatic diseases in China Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-29 Peng Lai, Haifeng Chen, Yunxia Yan, Mengru Du, Zhiling Zhao, Dandan Wang, Jun Liang, Lingyu Geng, Xue Xu, Lingyun Sun
Objectives At the end of 2022, the COVID-19 outbreak erupted in China, and BA.5.2 or BF.7 subtypes of Omicron novel variations were implicated in more than 90% of the cases. We created a real-world questionnaire survey to better understand how this new variant pandemic was affecting rheumatic patients in China. Methods During the COVID-19 outbreak in China, the subjects of this study were rheumatic
-
Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-29 Fernanda Espinosa-Bautista, Ma. Isabel Salazar-Sánchez, Malinalli Brianza-Padilla, Gloria León-Ávila, Adrián Hernández-Díazcouder, María Lilia Domínguez-López, Luis M. Amezcua-Guerra, Carlos Pineda
-
Comparative analysis of optical coherence tomography angiography (OCTA) results between Behçet’s disease patients and a healthy control group Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-29 Farzan Kianersi, Masoumeh Bazvand, Alimohammad Fatemi, Afsaneh Naderi Beni, Hamidreza Kianersi
-
Effects of a lifestyle intervention on cardiovascular risk factors in systemic lupus erythematosus patients: The study “Living well with lupus” Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-27 Sofia Mendes Sieczkowska, Bruna Caruso Mazzolani, Fabiana Infante Smaira, Marina Romero, Sandra Gofinet Pasoto, Ana Lúcia de Sá Pinto, Fernanda Rodrigues Lima, Victor Rodrigues De Oliveira, Serli Ueda, Fabiana Braga Benatti, Hamilton Roschel, Bruno Gualano
-
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-25
Abstract To examine racial/ethnic differences in rheumatoid arthritis (RA) disease burden and change in clinical outcomes over time. We included CorEvitas Rheumatoid Arthritis Registry patients from two time periods (2013–2015 and 2018–2020). Clinical Disease Activity Index (CDAI) (as a continuous measure and as a dichotomous measure) and the Health Assessment Questionnaire-Disability Index (HAQ-DI)
-
Study on the expression changes of lncRNA in patients with systemic lupus erythematosus and its correlation with Treg cells Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-23 Yu-jie Bu, Xing Cen, Yi-qi Wang, Ru Fan, Fen Zhang, Yu-qing Liu, Jia An, Jun Qiao, Sheng-xiao Zhang, Jun-wei Chen
-
Phenotype of Takayasu-like vasculitis and cardiopathy in patients with Blau syndrome Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-22 Linqing Zhong, Wei Wang, Xiaoyan Tang, Yu Zhang, Lijuan Gou, Lin Wang, Changyan Wang, Shan Jian, Meiying Quan, Zhenjie Zhang, Zhongxun Yu, Zhengqing Qiu, Min Wei, Hongmei Song
-
The Saudi consensus recommendations for the management of psoriatic arthritis (2023) Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-13 Ibrahim Abdulrazag Al-Homood, Nayef Al Ghanim, Mohammad Ibrahim Ahmad Fatani, Albader Hamza Hussein, Abdulaziz Mohammed Alolaiwi, Abdullah Abualiat, Eman Alqurtas, Bedor Abdullah Abdulrahman Alomari, Amr Mohammad Khardaly, Khalidah Ahmed Owdetallah Alenzi, Rayan G. Albarakati, Hajer Yousef Almudaiheem, Ahmed Al-Jedai, Maysa Tariq Yousef Eshmawi
-
Content analysis of patient support groups related to myositis on Facebook Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-12 Aiman Perween Afsar, Shounak Ghosh, Renil Sinu Titus, Karen Cheng, Arundati A. Kanawala, Peter Kerkhof, Jessica Day, Latika Gupta
-
Umbilical cord mesenchymal stem cells transplantation in patients with systemic sclerosis: a 5-year follow-up study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-11 Mihribangvl Alip, Dandan Wang, Shengnan Zhao, Siqi Li, Dongdong Zhang, Xiaoxiao Duan, Shiying Wang, Bingzhu Hua, Hong Wang, Huayong Zhang, Xuebing Feng, Lingyun Sun
-
Cumulative pulse methylprednisolone and its relation to disease activity, damage and mortality in systemic lupus erythematosus patients: A post hoc analysis of COMOSLE-EGYPT study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-10 Nesreen Sobhy, Yasser Ezzat, Sherif M. Gamal, Shada A. Ghoniem, Sarah S. Nasr, Shaimaa Badran, Ahmed Soliman, Nermeen Ahmed Fouad
-
Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-10 Liang Qiao, Shun Lv, Kai Meng, Jianmei Yang
-
Sex-specific differences in patients with psoriatic arthritis:a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR IV) Clin. Rheumatol. (IF 3.4) Pub Date : 2024-01-10 Shihao He, Fan Yang, Chaofan Lu, Yanhong Wang, Xinwang Duan, Hongbin Li, Lijun Wu, Yongfu Wang, Jinmei Su, Mengtao Li, Xiaomei Leng, Xiaofeng Zeng